Science Explorer Back to mapMap

Uterine Myomas and Treatments

Uterine Myomas and Treatments is a research topic within Obstetrics and Gynecology. Science Explorer counts 34k research works in it since 1950. 10.0% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on various aspects of uterine conditions and their treatments, including uterine leiomyoma (fibroids), hysterectomy, uterine sarcomas, uterine artery embolization, reproductive outcomes after different treatments, MRI guidance for treatment, the role of progesterone, and the impact on health-related quality of life. The cluster also covers epidemiological studies related to uterine conditions.

  • Uterine Leiomyoma
  • Uterine Fibroids
  • Hysterectomy
  • Uterine Sarcomas
  • Uterine Artery Embolization
  • Reproductive Outcomes
  • MRI Guidance
  • Progesterone Action
  • Health-related Quality of Life
  • Epidemiology
Research works
34k
fractional, since 1950
In the world top 10%
3.4k
per year above
Top-10% rate
10.0%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+8%
the tick is no change
Largest producer
United States
32% of the 10 largest, 2022-now

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Uterine Myomas and Treatments research?

By volume, the United States and China publish the most (1.5k and 976 works in 2022-now).

By volume, 2022-now

  1. 1 United States 1.5k works
  2. 2 China 976 works
  3. 3 India 646 works
  4. 4 Japan 324 works
  5. 5 Italy 277 works
  6. 6 Türkiye 229 works
  7. 7 United Kingdom 225 works
  8. 8 Germany 167 works
  9. 9 Spain 165 works
  10. 10 Russia 163 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 31.6%China: 21.1%India: 13.9%Japan: 7.0%6 others listed: 26.4%32%largest
United States1,465 · 31.6%China976 · 21.1%India646 · 13.9%Japan324 · 7.0%6 others listed1,226 · 26.4%

Shares of the rows listed above, not of the whole node.

Which institutions lead Uterine Myomas and Treatments research?

By volume in 2022-now, All India Institute of Medical Sciences publishes the most Uterine Myomas and Treatments research, followed by Mayo Clinic and Harvard University.

Who are the leading researchers in Uterine Myomas and Treatments?

The most-cited researchers publishing on Uterine Myomas and Treatments include Walter Churchill Willett, Trevor Hastie and Salim Yusuf.

  1. 1 Walter Churchill Willett United States 411k citations
  2. 2 Trevor Hastie United States 301k citations
  3. 3 Salim Yusuf Canada 294k citations
  4. 4 Patrick M. Bossuyt Netherlands 270k citations
  5. 5 Gordon Brent Mills United States 265k citations
  6. 6 JoAnn E. Manson United States 263k citations
  7. 7 Carlo La Vecchia Italy 258k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Uterine Myomas and Treatments?

The most cited paper in Uterine Myomas and Treatments is "Effects of Conjugated Equine Estrogen in Postmenopausal Women With Hysterectomy" (The Women's Health Initiative Steering Committee*, 2004), with 4,508 citations. Next come "Endometriosis" (3,064) and "High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence" (2,469).

Most cited papers
#PaperReleasedCitations
1 Effects of Conjugated Equine Estrogen in Postmenopausal Women With Hysterectomy The Women's Health Initiative Steering Committee* · JAMA Open access 14 Apr 2004 4,508
2 Endometriosis Linda C. Giudice, Lee C. Kao · The Lancet Nov 2004 3,064
3 High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence Donna D. Baird, David B. Dunson, Michael C. Hill et al. · American Journal of Obstetrics and Gynecology 2003 2,469
4 Endometriosis Krina T. Zondervan, Christian M. Becker, Stacey A. Missmer · New England Journal of Medicine 25 Mar 2020 2,271
5 Endometriosis: pathogenesis and treatment Paolo Vercellini, Paola Viganò, Edgardo Somigliana et al. · Nature Reviews Endocrinology Review 24 Dec 2013 1,979
All 100 most cited papers, with filters and sorting

Where is Uterine Myomas and Treatments research done?

The largest centres of Uterine Myomas and Treatments research in 2022-now are Beijing (China), Shanghai (China), New York (United States) and London (United Kingdom).

Largest cities, 2022-now

  1. 1 BeijingChina 113 works
  2. 2 ShanghaiChina 86 works
  3. 3 New YorkUnited States 85 works
  4. 4 LondonUnited Kingdom 81 works
  5. 5 TokyoJapan 81 works
  6. 6 SeoulSouth Korea 80 works
  7. 7 MoscowRussia 75 works
  8. 8 IstanbulTürkiye 72 works
  9. 9 ChengduChina 71 works
  10. 10 New DelhiIndia 69 works
See Uterine Myomas and Treatments on the map

Where is the best place to study Uterine Myomas and Treatments?

Among universities, judged by research, Università Cattolica del Sacro Cuore, Harvard University and Chongqing Medical University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 18.41%fractional works in this field (log) →share of work in the world top 10% →Università Cattolica…Johns Hopkins Univer…Chongqing Medical Un…Harvard University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Università Cattolica del Sacro CuoreItaly 66.724.5%8.3×22 +15.2%
2Harvard UniversityUnited States 66.615.8%2.9×56 -6.9%
3Chongqing Medical UniversityChina 63.119.9%8.2×28 +93.2%
4Johns Hopkins UniversityUnited States 58.621.5%3.4×32 -6.8%
5Sichuan UniversityChina 57.29.1%3.7×51 +99.6%
6University of FlorenceItaly 55.846.2%2.4×9 +0.6%
7All India Institute of Medical SciencesIndia 55.13.2%8.8×59 +57.8%
8McGill UniversityCanada 54.111.5%3.6×22 +30.2%
9Baylor College of MedicineUnited States 53.520.4%6.4×20 +9.5%
10Capital Medical UniversityChina 52.712.0%4.7×30 +18.8%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Uterine Myomas and Treatments, country by country

Is Uterine Myomas and Treatments research growing?

Output in 2022-2025 was 8% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Uterine Myomas and Treatments.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Uterine Myomas and Treatments as a percentage of every work published that year, 0.029% in 2024.

still counting0.020%0.040%Uterine Myomas and Treatments0.030% in 202519801990200020102020

Fractional works of Uterine Myomas and Treatments over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Uterine Myomas and Treatments10.2% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Uterine Myomas and Treatments. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.